What is a NIPT Test?
The NIPT (Non-Invasive Prenatal Test), also known as cell-free DNA (cfDNA) screening, is a sophisticated prenatal blood test that analyses small fragments of placental DNA circulating in the pregnant woman's bloodstream. These cell-free fetal DNA fragments make up approximately 10–20% of the total cfDNA in maternal blood and carry the genetic information of the developing baby. NIPT offers a safe and highly accurate way to screen for specific chromosomal abnormalities as early as 10 weeks of pregnancy — with no risk to the mother or baby.
The Clinical Benefits of NIPT
NIPT is widely regarded as a breakthrough in prenatal care because of its precision and safety:
- Unmatched Accuracy — detection rate above 99% for Down Syndrome (Trisomy 21), significantly higher than traditional Double Marker or Triple Marker screening
- Zero Risk to Pregnancy — only a simple maternal blood draw; no needles near the baby, no risk of miscarriage
- Comprehensive Screening — screens for Trisomy 21, Trisomy 18, Trisomy 13, sex chromosome abnormalities and (in advanced panels) microdeletion syndromes
- Early Insights — results available as early as 10 weeks, giving parents more time for genetic counselling and clinical planning
- Fetal Sex Determination — NIPT can identify fetal sex chromosomes (XX or XY). Note: reporting of fetal sex is regulated under Indian law (PNDT Act) and is not reported in India.
What Conditions Does NIPT Screen For?
| Condition | Chromosomal Cause | Clinical Features |
|---|---|---|
| Down Syndrome | Trisomy 21 (extra chromosome 21) | Intellectual disability, characteristic facial features, heart defects |
| Edwards Syndrome | Trisomy 18 (extra chromosome 18) | Severe intellectual disability, organ malformations; often fatal in infancy |
| Patau Syndrome | Trisomy 13 (extra chromosome 13) | Severe brain, heart and organ defects; often fatal in infancy |
| Turner Syndrome | Monosomy X (45,X) | Short stature, infertility, heart defects in females |
| Klinefelter Syndrome | XXY | Male hypogonadism, infertility, learning difficulties |
| Triple X Syndrome | XXX | Usually mild; tall stature, learning difficulties in females |
| Jacob's Syndrome | XYY | Usually mild; tall stature in males |
| Microdeletion Syndromes (advanced panels) | Small deletions of chromosomal segments | DiGeorge, Prader-Willi, Angelman, Wolf-Hirschhorn syndromes |
NIPT vs Double Marker vs Amniocentesis — Key Differences
- Double Marker Test (11–13 weeks) — blood test measuring free beta-HCG and PAPP-A alongside NT ultrasound. Detects Down Syndrome with about 85–90% sensitivity. Lower cost. Good first-line screen. Recommended for all pregnancies.
- NIPT (10+ weeks) — cfDNA screening. Detects Down Syndrome with above 99% sensitivity. Higher cost but much more accurate. Ideal when Double Marker is high-risk or for women who want the most accurate non-invasive screen.
- Amniocentesis (15–20 weeks) — Diagnostic (not screening). Analyses fetal cells from amniotic fluid. 100% diagnostic accuracy. Carries 0.5–1% miscarriage risk. Recommended when NIPT or Double Marker is high-risk to confirm the diagnosis before any decision is made.
- NIPT is a screening test, not a diagnostic test — a high-risk NIPT result must always be confirmed by amniocentesis or CVS before any clinical decision. A low-risk NIPT result does not guarantee a normal pregnancy but significantly reduces the likelihood of these specific conditions.
When is NIPT Recommended?
NIPT is recommended for:
- All pregnant women from 10 weeks onwards who want the most accurate non-invasive prenatal screen
- Women aged 35 and above (Advanced Maternal Age) — higher baseline risk of chromosomal abnormalities
- Women with a high-risk result on Double Marker or Triple Marker screening
- Women with a previous pregnancy affected by chromosomal abnormality
- Women with ultrasound findings suggesting chromosomal abnormality (increased NT, absent nasal bone, echogenic bowel)
- Women with a family history of chromosomal conditions
- IVF pregnancies — higher risk of chromosomal abnormalities
- Women who want to avoid invasive testing (amniocentesis) where possible
NIPT Test Price in Kolkata
No fasting required | From 10 weeks gestation | Results in 7–14 working days | Genetic counselling available
Tests in the Prenatal Screening Pathway
- Double Marker + NT Scan (11–13 weeks) — first trimester combined screening; ordered before or alongside NIPT
- Anomaly Scan / Level 2 USG (18–20 weeks) — detailed structural survey of the fetus; ordered alongside or after NIPT
- Triple Marker (15–20 weeks) — second trimester biochemical screen; an alternative to NIPT for women who miss the first trimester window
- Beta-HCG (Quantitative) — confirms pregnancy and gestational age before NIPT is ordered
- Blood Group & Rh Typing — mandatory antenatal test ordered alongside prenatal screening
- Amniocentesis — the definitive diagnostic follow-up when NIPT is high-risk
Home Collection for NIPT in Kolkata
Apollo Diagnostics provides home blood sample collection for NIPT across Nagerbazar, Dum Dum, South Dum Dum and surrounding North and Central Kolkata areas. NIPT requires a specific blood collection protocol — our phlebotomists use dedicated cfDNA collection tubes (BCT tubes) with special preservatives to stabilise cell-free DNA during transport to the genetics laboratory.
- Home collection available: 7:00 AM – 2:30 PM Daily
- No fasting required
- Dedicated cfDNA collection tubes used
- Sample sent to specialised genetics laboratory
- Results in 7–14 working days
- Pre-test genetic counselling with your gynaecologist strongly recommended
→ Apollo Diagnostics Nagerbazar → Full List of Individual Tests → Book Home Collection → Full Body Checkup Packages
No comments:
Post a Comment